NCT06821503 2026-03-10Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort CChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1/2 Recruiting72 enrolled